University of California, San Diego: Leukemia, Lymphocytic, Chronic, B-Cell trials
The registry lists 10 Leukemia, Lymphocytic, Chronic, B-Cell studies with University of California, San Diego as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 6Phase 2 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL PatientsCompletedNCT04981912Phase 1Results posted
- Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961CompletedNCT02860676Phase 1Results posted
- Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.CompletedNCT02315768Phase 1/2Results posted
- Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)CompletedNCT01199575Phase 2Results posted
- A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic LeukemiaTerminatedNCT00949988Phase 1/2Results posted
- Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on VenetoclaxActive, not recruitingNCT04501939Phase 2
- Lenalidomide and Obinutuzumab for Previously Untreated CLLWithdrawnNCT02371590Phase 2
- Evaluation of the Immune Restoration Potential Of LenalidomideWithdrawnNCT02371577Phase 2
- A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP)Active, not recruitingNCT02229422Phase 1/2
- Pharmacodynamic (PD) Study of Intranodal Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)CompletedNCT00850057Phase 1